Skip to main content
logo
Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.890
+0.100 (3.58%)
Sep 15, 2026, 4:00 PM EDT - Market closed

Acumen Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
209128103222221274
Market Cap Growth
161.39%23.68%-53.53%0.62%-19.22%-
Enterprise Value
13023-126-602144
Last Close Price
2.892.111.723.845.406.76

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.651.820.570.831.171.22
P/TBV Ratio
3.651.820.570.831.171.22

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.550.450.160.120.00-
Net Debt / Equity Ratio
-1.37-1.22-1.11-1.03-1.02-1.00
Net Debt / EBITDA Ratio
0.750.691.774.504.2811.54
Net Debt / FCF Ratio
0.860.742.346.385.4812.55
Inventory Turnover
---284.97229.51141.44
Quick Ratio
2.383.936.2418.8122.7537.76
Current Ratio
2.474.076.4619.0123.0838.60
Return on Equity (ROE)
-120.50%-96.20%-45.60%-22.98%-20.71%-76.44%
Return on Assets (ROA)
-45.77%-42.78%-25.96%-15.08%-13.25%-8.91%
Return on Capital Employed (ROCE)
-152.40%-133.40%-53.90%-20.60%-24.00%-8.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-50.26%-94.93%-99.02%-23.55%-19.39%-36.77%
FCF Yield
-43.92%-90.47%-83.45%-19.38%-15.98%-6.58%
Buyback Yield / Dilution
-6.39%-0.91%-23.46%-19.72%-102.43%-4685.59%
SEC Filings: 10-K · 10-Q